HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Jiang Selected Research

cercosporamide

10/2020Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Jiang Research Topics

Disease

124Neoplasms (Cancer)
09/2022 - 01/2002
52Infections
05/2022 - 08/2003
25Neoplasm Metastasis (Metastasis)
07/2022 - 06/2008
25Breast Neoplasms (Breast Cancer)
01/2022 - 11/2006
23Inflammation (Inflammations)
10/2022 - 02/2008
18Carcinogenesis
07/2021 - 04/2008
15Osteoporosis
07/2022 - 09/2002
13Hepatocellular Carcinoma (Hepatoma)
05/2021 - 01/2014
13Lung Neoplasms (Lung Cancer)
03/2021 - 04/2005
12Pain (Aches)
07/2022 - 10/2003
12Glioma (Gliomas)
01/2022 - 08/2015
12Insulin Resistance
01/2020 - 11/2008
10Osteogenesis Imperfecta (Lobstein Disease)
01/2022 - 10/2011
10Fibrosis (Cirrhosis)
08/2020 - 04/2009
9Hypophosphatemia
12/2022 - 12/2007
9Body Weight (Weight, Body)
07/2022 - 09/2007
9Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 06/2003
9Carcinoma (Carcinomatosis)
01/2022 - 09/2009
9Bone Resorption
01/2022 - 02/2005
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 06/2014
9Hypoxia (Hypoxemia)
04/2021 - 12/2010
8Necrosis
01/2022 - 08/2012
8Sepsis (Septicemia)
01/2022 - 04/2017
8Schizophrenia (Dementia Praecox)
01/2022 - 07/2013
8Lymphatic Metastasis
01/2022 - 03/2010
8Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 10/2014
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2015
7Hyperplasia
01/2022 - 11/2006
7Seizures (Absence Seizure)
01/2022 - 02/2012
7Hypoparathyroidism
11/2021 - 02/2009
7Leukemia
10/2021 - 10/2003
7Pancreatic Neoplasms (Pancreatic Cancer)
05/2021 - 02/2010
7Hypocalcemia
06/2020 - 02/2009
7Hypercalciuria
11/2018 - 02/2009
7Rickets (Rachitis)
05/2016 - 12/2007
6Hypercalcemia (Milk Alkali Syndrome)
03/2022 - 09/2009
6Nasopharyngeal Carcinoma
01/2022 - 01/2018
6Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 01/2007
6Allergic Rhinitis
01/2021 - 03/2009
5Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 11/2013
5Cardiotoxicity
04/2022 - 05/2017
5Wounds and Injuries (Trauma)
04/2022 - 08/2003
5Adenocarcinoma of Lung
10/2021 - 08/2006
5Dysbiosis
07/2021 - 02/2019

Drug/Important Bio-Agent (IBA)

68Proteins (Proteins, Gene)FDA Link
08/2022 - 05/2006
27Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2003
21Messenger RNA (mRNA)IBA
01/2022 - 01/2007
20Pharmaceutical PreparationsIBA
03/2022 - 01/2008
20EnzymesIBA
01/2021 - 02/2005
18Alkaline PhosphataseIBA
07/2022 - 10/2003
15Long Noncoding RNAIBA
05/2022 - 06/2014
15DNA (Deoxyribonucleic Acid)IBA
10/2019 - 04/2005
14MicroRNAs (MicroRNA)IBA
02/2022 - 07/2010
14CalciumIBA
11/2021 - 09/2002
14Glucose (Dextrose)FDA LinkGeneric
01/2021 - 12/2008
13Peptides (Polypeptides)IBA
06/2022 - 05/2009
13ChromatinIBA
01/2022 - 09/2006
13Vitamin DFDA LinkGeneric
12/2020 - 11/2008
12Biological ProductsIBA
10/2022 - 06/2007
12Zoledronic Acid (Zometa)FDA Link
01/2022 - 08/2015
11Carbapenems (Carbapenem Antibiotics)IBA
01/2022 - 11/2017
11Histones (Histone)IBA
01/2022 - 09/2006
11Small Interfering RNA (siRNA)IBA
03/2021 - 03/2010
10Anti-Bacterial Agents (Antibiotics)IBA
09/2022 - 08/2009
10LipidsIBA
03/2022 - 02/2008
10Fibroblast Growth Factor-23IBA
01/2022 - 05/2010
10Parathyroid Hormone (Parathormone)IBA
01/2021 - 02/2009
10Alendronate (Alendronate Sodium)FDA LinkGeneric
12/2020 - 09/2002
10Diphosphonates (Bisphosphonates)IBA
12/2020 - 09/2009
9RNA (Ribonucleic Acid)IBA
05/2022 - 11/2004
9CytokinesIBA
02/2022 - 10/2003
8Ethanol (Ethyl Alcohol)IBA
04/2022 - 01/2012
8Collagen Type I (Type I Collagen)IBA
01/2022 - 10/2003
8Dinoprostone (PGE2)FDA Link
01/2022 - 09/2013
8hydroxide ionIBA
01/2021 - 04/2012
8Therapeutic UsesIBA
01/2021 - 01/2012
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 07/2014
7LigandsIBA
01/2022 - 05/2013
7Phosphorus (Red Phosphorus)IBA
09/2021 - 01/2012
7Insulin (Novolin)FDA Link
04/2021 - 01/2017
7Blood Glucose (Blood Sugar)IBA
04/2021 - 09/2010
7oxidized low density lipoproteinIBA
01/2021 - 12/2012
6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2014
6Tigecycline (Tygacil)FDA Link
01/2022 - 01/2014
6Retinaldehyde (Retinal)IBA
01/2022 - 04/2014
6AntigensIBA
01/2022 - 07/2011
6Phosphates (Orthophosphate)IBA
01/2022 - 12/2007
6Triglycerides (Triacylglycerol)IBA
04/2021 - 09/2010
6Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021 - 09/2011
6Transcription Factors (Transcription Factor)IBA
01/2021 - 12/2012
6CateninsIBA
01/2021 - 07/2014
625-hydroxyvitamin DIBA
02/2018 - 04/2012
5Monoclonal AntibodiesIBA
06/2022 - 11/2007
5Immunoglobulins (Immunoglobulin)IBA
01/2022 - 12/2007

Therapy/Procedure

51Therapeutics
09/2022 - 03/2009
16Drug Therapy (Chemotherapy)
01/2021 - 10/2003
13Aftercare (After-Treatment)
03/2022 - 10/2003
6Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 01/2017
6Immunotherapy
01/2022 - 04/2014
5Length of Stay
01/2022 - 01/2019